Enhancing Antimicrobial Susceptibility Testing in the Pharmaceutical Industry: A Crucial Step Towards Combatting Drug Resistance

 In the realm of pharmaceuticals, where every advancement and innovation is aimed at improving human health, antimicrobial susceptibility testing (AST) stands out as a pivotal process. As the threat of antimicrobial resistance (AMR) looms larger than ever, pharmaceutical companies find themselves at the forefront of the battle against drug-resistant pathogens. In this blog, we delve into the significance of AST within the pharmaceutical industry and explore how advancements in this field are shaping the future of medicine.

According to the report published by Allied Market Research, the global antimicrobial susceptibility testing market generated $3.04 billion in 2020, and is anticipated to reach $4.73 billion by 2030, manifesting a CAGR of 5.8% from 2021 to 2030. 

Request Sample Copy of the Report https://www.alliedmarketresearch.com/request-sample/A10282

Understanding Antimicrobial Susceptibility Testing

Antimicrobial susceptibility testing is a laboratory technique used to determine the effectiveness of antimicrobial agents against specific microorganisms. By assessing the susceptibility of bacterial, fungal, or viral pathogens to various antibiotics or antifungal agents, AST helps guide clinicians in selecting the most appropriate treatment for infectious diseases. In the pharmaceutical industry, AST serves multiple critical purposes:

1. Drug Development and Optimization: Pharmaceutical companies rely on AST to evaluate the potency and efficacy of new antimicrobial compounds during the drug development process. By testing these compounds against a panel of clinically relevant pathogens, researchers can identify potential candidates for further development and optimization.

2. Quality Control: Ensuring the consistency and quality of antimicrobial products is paramount in the pharmaceutical industry. AST plays a crucial role in quality control by verifying the potency of manufactured antibiotics and confirming their efficacy against target pathogens. This helps maintain regulatory compliance and safeguard public health.

3. Surveillance and Epidemiology: Monitoring antimicrobial resistance patterns is essential for understanding the global spread of drug-resistant pathogens. Pharmaceutical companies contribute to surveillance efforts by conducting AST on clinical isolates collected from various regions. This data enables researchers to track trends in resistance, identify emerging threats, and inform public health strategies.

Challenges and Innovations

Despite its importance, antimicrobial susceptibility testing is not without challenges. Traditional methods, such as disk diffusion and broth microdilution, are time-consuming, labor-intensive, and may lack accuracy in predicting clinical outcomes. Moreover, the emergence of multidrug-resistant pathogens necessitates continuous innovation in AST techniques and technologies. Fortunately, the pharmaceutical industry is at the forefront of developing novel approaches to address these challenges:

Do Purchase Enquiry https://www.alliedmarketresearch.com/purchase-enquiry/A10282

1. Automation and High-Throughput Screening: Automated AST systems streamline the testing process, reducing turnaround times and increasing throughput. These systems leverage robotics, artificial intelligence, and advanced imaging technologies to perform rapid susceptibility testing on large numbers of samples simultaneously. By accelerating the pace of AST, pharmaceutical companies can expedite drug development and enhance surveillance capabilities.

2. Molecular and Genomic Techniques: Molecular methods, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), offer insights into the genetic mechanisms underlying antimicrobial resistance. Pharmaceutical researchers utilize these techniques to identify resistance genes, characterize microbial populations, and track transmission pathways. Integrating molecular data with AST results enhances the precision of resistance detection and enables personalized treatment approaches.

3. Microfluidics and Lab-on-a-Chip Platforms: Microfluidic devices enable miniaturized and portable AST systems that require minimal sample volumes and offer rapid results. Lab-on-a-chip platforms integrate sample preparation, culture, and analysis into a single microscale device, revolutionizing the way AST is performed. These technologies hold promise for point-of-care testing in resource-limited settings and facilitate real-time monitoring of antimicrobial resistance in clinical settings.

Conclusion

In the fight against antimicrobial resistance, the pharmaceutical industry plays a central role in developing innovative solutions to combat drug-resistant pathogens. Antimicrobial susceptibility testing serves as a cornerstone of this endeavor, guiding drug development, ensuring product quality, and informing public health initiatives. By harnessing cutting-edge technologies and embracing continuous innovation, pharmaceutical companies can stay ahead of the evolving threat of antimicrobial resistance and pave the way for a healthier future.

Incorporating these industry-specific nuances, pharmaceutical companies can elevate their contributions to the fight against antimicrobial resistance, ultimately safeguarding the efficacy of antibiotics and preserving human health for generations to come.

Know More- https://www.alliedmarketresearch.com/antimicrobial-susceptibility-testing-market-A10282

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Revolutionizing Patient Care: The Advances in Hematology Diagnostics

 In the rapidly evolving field of healthcare, hematology diagnostics stand out as a beacon of progress, significantly influencing patient care. This specialized branch of medicine focuses on the study, diagnosis, treatment, and prevention of diseases related to blood. Over recent years, advancements in hematology diagnostics have revolutionized how medical professionals approach blood disorders, leading to earlier detection, more accurate diagnoses, and improved treatment outcomes.

The global hematology diagnostics market was valued at $10.94 billion in 2022 and is projected to reach $16.87 billion by 2032, registering a CAGR of 4.4% from 2023 to 2032. The Evolution of Hematology Diagnostics

Traditionally, hematology diagnostics relied heavily on manual techniques and visual examination of blood samples under a microscope. While these methods have served their purpose for many years, they are time-consuming and often subject to human error. Fast forward to the present day, the landscape of hematology diagnostics has transformed with the integration of automated systems and cutting-edge technologies, enhancing both the efficiency and precision of diagnostic processes.

Request Sample of the Report on Hematology Diagnostics Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/11356 

Breakthrough Technologies in Hematology

One of the most significant advancements in the field is the advent of high-throughput automated hematology analyzers. These sophisticated machines can process hundreds of samples per hour, providing detailed information on various blood parameters, such as red and white blood cell counts, hemoglobin levels, and platelet counts. Automation has not only expedited the diagnostic process but also minimized the chances of manual errors, ensuring more reliable results.

Flow cytometry is another groundbreaking technology that has reshaped hematology diagnostics. This technique allows for the detailed analysis of the physical and chemical characteristics of particles in a fluid as it passes through a laser. Flow cytometry is invaluable in diagnosing and monitoring blood cancers, such as leukemia and lymphoma, by identifying abnormal cells and their progression.

Moreover, molecular diagnostics have brought about a paradigm shift in hematology by enabling the genetic profiling of blood disorders. Techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) can detect genetic mutations and alterations at the molecular level, facilitating the diagnosis of hereditary conditions, and guiding targeted treatment strategies.

The Impact on Patient Care

The advancements in hematology diagnostics have had a profound impact on patient care. Early detection of blood disorders is now possible, often before the onset of symptoms, allowing for timely intervention and better management of the disease. Furthermore, the precision of modern diagnostic tools has led to personalized treatment plans. By understanding the specific characteristics of a patient's condition, healthcare providers can tailor therapies to achieve the best possible outcomes, reducing the likelihood of adverse reactions and improving the quality of life for patients.

Additionally, the efficiency and automation of diagnostic procedures have significantly reduced the workload on laboratory staff, allowing for a quicker turnaround time for test results. This not only benefits patients, who receive faster diagnoses and start their treatment sooner, but also healthcare systems, which can operate more efficiently and effectively.

Looking to the Future

As we look to the future, the field of hematology diagnostics is poised for even greater advancements. Research is ongoing into developing more sophisticated analytical tools and exploring the potential of artificial intelligence (AI) and machine learning (ML) in enhancing diagnostic accuracy and predictive analytics. The integration of these technologies promises to further revolutionize patient care, making the diagnosis and treatment of blood disorders more efficient, precise, and personalized than ever before.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/A06095

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hematology diagnostics market analysis from 2022 to 2032 to identify the prevailing hematology diagnostics market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the hematology diagnostics market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global hematology diagnostics market trends, key players, market segments, application areas, and market growth strategies.
  
  

Key findings of the study 
o    By product type, the hematology consumables segment was the highest contributor to the market in 2022.
o    By test type, the complete blood count (CBC) segment dominated the hematology diagnostics industry in 2022.
o    By end user, the diagnostic laboratories segment was the highest contributor to the market in 2022.
o    Region wise, North America generated the largest revenue in 2022, whereas Asia-Pacific is anticipated to grow at the          highest CAGR during the forecast period.

In conclusion, the advances in hematology diagnostics are a testament to the incredible strides made in medical science, significantly improving the prognosis and quality of life for patients with blood disorders. As technology continues to evolve, the future of hematology diagnostics looks bright, with the promise of even more innovative solutions on the horizon.

Know More- https://www.alliedmarketresearch.com/press-release/hematology-diagnostics-market.html

 About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Innovations in Drug Delivery Devices: Revolutionizing Healthcare

 In the realm of healthcare, advancements in drug delivery devices are fundamentally altering the landscape of treatment methodologies. These devices serve as the bridge between pharmaceutical innovation and patient well-being, offering precise, efficient, and often less invasive ways to administer medication. From simple syringes to sophisticated implantable pumps, the evolution of drug delivery devices has been remarkable, significantly enhancing therapeutic outcomes while minimizing adverse effects. Let's delve into the realm of these innovations and explore how they are revolutionizing healthcare.

 The global drug delivery devices market size was valued at $19 billion in 2018, and is expected to reach $26.7 billion by 2026, registering a CAGR of 4.3% from 2019 to 2026.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/A06095

The Need for Advanced Drug Delivery Devices

Traditionally, administering medication has often been a straightforward process involving pills or injections. However, such conventional methods may not always be optimal for various patient populations. Factors such as patient compliance, precise dosage requirements, and the need for localized treatment have underscored the necessity for more sophisticated drug delivery systems.

Moreover, certain medical conditions demand continuous or controlled release of medication over extended periods. In such cases, conventional methods fall short in providing the desired therapeutic efficacy. This is where advanced drug delivery devices come into play, offering solutions tailored to specific patient needs.

Types of Drug Delivery Devices

1. Implantable Drug Delivery Systems: These devices are designed to deliver medication directly into the bloodstream or targeted areas within the body. They can be implanted either temporarily or permanently, providing sustained release of medication over extended periods. Implantable pumps, for instance, are capable of delivering precise doses of medication directly to the spinal cord or brain for pain management or treatment of neurological disorders.

2. 
   

3. Transdermal Drug Delivery Systems: Transdermal patches have gained popularity for delivering medication through the skin, offering a non-invasive and convenient alternative to oral or injectable routes. These patches are particularly useful for delivering drugs with poor oral bioavailability or those requiring controlled release. They are widely utilized for hormone therapy, pain management, and nicotine replacement therapy.

4. 
   

5. Inhalation Devices: Inhalers and nebulizers are indispensable tools for administering medication directly to the respiratory tract. They are commonly used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Inhalation devices ensure rapid onset of action and high bioavailability of medication, making them highly effective in managing respiratory ailments.

6. 
   

7. Smart Drug Delivery Devices: With the advent of digital health technologies, smart drug delivery devices have emerged as a promising innovation in personalized medicine. These devices are equipped with sensors and connectivity features that enable remote monitoring of patient adherence and physiological parameters. Smart insulin pumps, for instance, can automatically adjust insulin delivery based on real-time glucose levels, offering precise and personalized diabetes management.

8. 
   

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/A06095

Benefits of Advanced Drug Delivery Devices

• Enhanced Therapeutic Efficacy: Advanced drug delivery devices enable precise dosing and targeted delivery of medication, maximizing therapeutic efficacy while minimizing side effects.
• Improved Patient Compliance: Non-invasive and user-friendly drug delivery systems promote better patient acceptance and adherence to treatment regimens, thereby improving overall outcomes.
• Customized Treatment Options: These devices allow for personalized treatment approaches tailored to individual patient needs, leading to optimized therapeutic outcomes.
• Reduced Healthcare Costs: By minimizing hospital visits, complications, and the need for frequent dosing adjustments, advanced drug delivery devices contribute to cost savings in healthcare delivery.

Challenges and Future Directions

Despite their numerous advantages, advanced drug delivery devices are not without challenges. Issues such as device compatibility, patient training, and regulatory hurdles need to be addressed to ensure widespread adoption and efficacy. Moreover, ongoing research is focused on enhancing the functionality, biocompatibility, and connectivity of these devices to further improve patient outcomes.

In conclusion, the evolution of drug delivery devices represents a paradigm shift in modern healthcare, offering innovative solutions to age-old challenges in medication administration. As technology continues to advance, these devices will play an increasingly pivotal role in delivering safe, effective, and personalized therapies to patients worldwide, ushering in a new era of precision medicine.

Know More- https://www.alliedmarketresearch.com/drug-delivery-devices-market-A06095

About US- Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact US- David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free: +1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Follow Us on: LinkedIn Twitter

Enhancing Ocular Health: The Promise of Advanced Drug Delivery Techniques

 Introduction:

The ocular drug delivery market size was valued at $67.7 billion in 2022, and is estimated to reach $115.5 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032.

The eyes are not only the windows to the soul but also vital organs that require precise and effective treatment in case of diseases or disorders. Ocular drug delivery plays a crucial role in managing various eye conditions, ranging from common issues like dry eyes to more severe ailments such as glaucoma and age-related macular degeneration. However, traditional methods of drug administration often fall short in providing optimal therapeutic outcomes due to anatomical barriers and physiological factors unique to the eye. In recent years,

advancements in drug delivery technologies have revolutionized the treatment landscape, offering safer, more efficient, and patient-friendly solutions. This blog explores the evolution of ocular drug delivery and highlights some promising innovations in the field.

Request Sample of the Report on Ocular Drug Delivery Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/3646 

Challenges in Ocular Drug Delivery: The eye presents several challenges for drug delivery, including limited bioavailability, rapid clearance, and the presence of protective barriers such as the cornea, conjunctiva, and blood-retinal barrier. Traditional delivery methods such as eye drops and ointments struggle to overcome these barriers, leading to low drug penetration and frequent dosing requirements. Moreover, systemic administration routes like oral or intravenous delivery often result in poor ocular drug concentrations and systemic side effects. Thus, there is a critical need for innovative approaches that can enhance drug delivery to the eye while minimizing adverse effects.

Innovations in Ocular Drug Delivery:

1. Nanotechnology: Nanoparticles offer a promising platform for ocular drug delivery due to their small size, high surface area-to-volume ratio, and ability to encapsulate a wide range of therapeutic agents. Nanoparticle-based formulations can improve drug solubility, prolong drug release, and target specific ocular tissues, thereby enhancing efficacy and reducing dosing frequency. Liposomes, polymeric nanoparticles, and dendrimers are examples of nanocarriers that have shown potential in delivering drugs to the eye.

2. 
   

3. Hydrogels and Inserts: Hydrogels are cross-linked polymer networks capable of absorbing and retaining large amounts of water. These materials can be formulated into various ocular inserts, such as contact lenses, films, or implants, to provide sustained drug release and prolonged residence time on the ocular surface. Hydrogel-based delivery systems offer the advantage of non-invasiveness and improved patient compliance compared to conventional dosage forms.

4. 
   

5. In situ Gelation Systems: In situ gelation systems are liquid formulations that undergo gelation upon instillation into the eye, forming a gel with extended residence time and controlled drug release properties. These systems can be designed to respond to environmental stimuli such as temperature, pH, or ion concentration, allowing for tailored drug release profiles and enhanced ocular bioavailability. Injectable depots and thermosensitive hydrogels are examples of in situ gelation technologies that hold promise for ocular drug delivery.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/3646 

1. Microneedle Technology: Microneedles are microscopic needles typically ranging from tens to hundreds of micrometers in length, capable of penetrating the ocular barriers and delivering drugs to precise locations within the eye. Microneedle-based delivery offers advantages such as painless administration, improved drug penetration, and reduced systemic exposure. Dissolving microneedles, coated microneedles, and hollow microneedles are among the various designs being explored for ocular drug delivery applications.

Future Perspectives: The field of ocular drug delivery continues to evolve rapidly, driven by advancements in materials science, nanotechnology, and biomedical engineering. Future research efforts are focused on overcoming remaining challenges such as achieving sustained drug release, enhancing tissue specificity, and ensuring long-term safety and efficacy. Personalized medicine approaches based on patient-specific factors such as genetics, disease stage, and ocular anatomy hold promise for optimizing treatment outcomes and minimizing adverse effects. By harnessing the power of innovative drug delivery technologies, we can unlock new possibilities for preserving vision and improving the quality of life for patients with ocular diseases.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/3646 

Conclusion: Ocular drug delivery represents a dynamic and rapidly advancing field that holds tremendous potential for transforming the treatment of eye disorders. By overcoming the inherent challenges of drug delivery to the eye and leveraging cutting-edge technologies, researchers and clinicians can develop safer, more effective, and patient-friendly therapies. From nanotechnology-based formulations to microneedle-mediated delivery systems, the future of ocular drug delivery is bright, offering hope for millions of individuals affected by eye conditions worldwide.

Know More- https://www.alliedmarketresearch.com/press-release/ocular-drug-delivery-market.html

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975 
help@alliedmarketresearch.com  
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter